References
- McCormack A, Edmondson-Jones M, Somerset S, Hall D. A systematic
review of the reporting of tinnitus prevalence and severity.Hear Res. 2016;337:70-9. doi:10.1016/j.heares.2016.05.009.
- Tunkel DE, Bauer CA, Sun GH, et al. Clinical practice guideline:
Tinnitus. Otolaryngol - Head Neck Surg (United States).2014;151(2):S1-S40. doi:10.1177/0194599814545325.
- Wegner I, Hall DA, Smit AL, McFerran D, Stegeman I. Betahistine for
tinnitus. Cochrane Database Syst Rev. 2018 Dec
28;12(12):CD013093. doi: 10.1002/14651858. .
- Piccirillo JF, Rodebaugh TL, Lenze EJ. Tinnitus. JAMA .
2020;323(15):1497-98. doi:10.1001/JAMA.2020.0697.
- McFerran DJ, Stockdale D, Holme R, Large CH, Baguley DM. Why is there
no cure for tinnitus? Front Neurosci . 2019;13:1-13.
doi:10.3389/fnins.2019.00802.
- Van Esch B, van der Zaag-Loonen H, Bruintjes T, van Benthem PP.
Betahistine in Ménière’s Disease or Syndrome: A Systematic Review.Audiol Neurotol. Published online January, 2022;27(1):1-33.
doi: 10.1159/000515821.
- Mcferran D, Hoare DJ, Carr S, Ray J, Stockdale D. Tinnitus services in
the United Kingdom: A survey of patient experiences. BMC Health
Serv Res. 2018 Feb 13;18(1):110. doi: 10.1186/s12913-018-2914-3.
- Dziadziola DJK, Laurikainen DEL, Rachel DJD, Quirk DWS. Betahistine
Increases Vestibular Blood Flow. Otolaryngol Head Neck Surg.2016;120(3):400-5. doi:10.1016/S0194-5998(99)70283-4.
- Unemoto H, Sasa M, Takaori S, Ito J, Matsuoka I. Inhibitory effect of
betahistine on polysynaptic neurons in the lateral vestibular nucleus.Arch Otorhinolaryngol. 1982;236(3):229-36.
doi:10.1007/BF00454214.
- Ganança MM, Caovilla HH, Gazzola JM, Ganança CF, Ganança FF.
Betahistine in the treatment of tinnitus in patients with vestibular
disorders. Braz J Otorhinolaryngol. 2011;77(4):499-503.
doi:10.1590/S1808-86942011000400014.
- Sereda M.et al. A Process for Prioritising Systematic Reviews in
Tinnitus. Int J Audiol. 2020; 59 (8): 640–6.
doi:10.1080/14992027.2020.1733677.
- Gupta A, Monsell EM. Which Patients With Asymmetric Sensorineural
Hearing Loss Should Undergo Imaging? Laryngoscope.2018;128(9):1990-91. doi:10.1002/lary.27118.
- Electronic Medicines Compendium. Betahistine dihydrochloride.https://www.medicines.org.uk/emc/product/7053/smpc. Published
2014. Accessed May 10, 2022.
- Alves FPE, Cunha F, Onishi ET, Branco-Barreiro FCA, Ganança FF.
Tinnitus handicap inventory: cross-cultural adaptation to Brazilian
Portuguese. Pro Fono. 2005;17(3):303-10.
doi:10.1590/S0104-56872005000300004.
- Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus
handicap inventory. Arch Otolaryngol - Head Neck Surg.1996;122(2):143-8. doi:10.1001/archotol.1996.01890140029007.
- Busner J, Targum SD. The clinical global impressions scale: Applying a
research tool in clinical practice. Psychiatry (Edgmont).2007;4(7):28-37.
http://www.ncbi.nlm.nih.gov/pubmed/20526405. Accessed May 7, 2021.
Zeman F, Koller M, Figueiredo R, et al. Tinnitus handicap inventory
for evaluating treatment effects: Which changes are clinically
relevant? Otolaryngol - Head Neck Surg. 2011;145(2):282-7.
doi:10.1177/0194599811403882.
Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M; BEMED
Study Group. Efficacy and safety of betahistine treatment in patients
with Meniere’s disease: Primary results of a long term, multicentre,
double blind, randomised, placebo controlled, dose defining trial
(BEMED trial). BMJ. 2016;352:h6816. doi:10.1136/bmj.h6816.